OmniComm Systems, Inc.
Fort Lauderdale, FL, December 16, 2015 - OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, announces major milestone achievements for TrialOne. TrialOne is used in a variety of clinics, supporting both healthy and patient driven early phase studies across a multitude of therapeutic areas and study types. Within one year TrialOne has been deployed in early phase clinics that account for over 1,100 beds, 1,500 users and over 470 clinical studies annually.
TrialOne is the leading proactive eSource and site automation solution for early phase clinical sites. TrialOne is a comprehensive set of modules that drive efficiencies, reduce timelines and decrease costs through faster and more directed volunteer recruitment, easy to build schedule based workflows, real-time bedside data collection, direct data capture from devices, sample processing automation and modern data processing. The browser-based, tablet compatible system provides an advanced platform for automating clinic operations, complies with FDA 21 CFR part 11, and supports data standards such as CDISC for faster and easier exporting and reporting of data.
- Seoul National University Hospital Clinical Trials Center goes live with TrialOne
- Global top 10 CRO signs five year, multi-million dollar contract for TrialOne
- Global top 5 CRO goes live with TrialOne at three world-wide sites
- Global top 5 CRO phase I clinic goes live in UK
- First electronic health record (EHR) and TrialOne integration completed and in production
“This year marks significant milestones for TrialOne – with numerous global locations going live for multiple clients and the addition of another global top 10 CRO to our growing customer base,” says Kuno van der Post, SVP of business development, OmniComm Systems. “Our TrialOne team of early phase experts provides outstanding quality, reliability, delivery speed and service to our clients enabling them to achieve the best possible business outcomes. OmniComm continues to invest significantly in the development of the TrialOne suite making it a key reason why we continue to be the clear leader in this market sector.”
- OmniComm Systems® Announces the Go-Live of TrialOne® at Seoul National University Hospital
- OmniComm Systems® Announces New Release of TrialOne®
About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from over 4,000 clinical trials. For more information, visit www.omnicomm.com.
OmniComm, TrialMaster, TrialOne, and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.